SeqOnce Biosciences Inc. Email Format
Biotechnology ResearchCalifornia, United States0-1 Employees
SeqOnce Biosciences, Inc. is a biotechnology company based in Carlsbad, California, that focused on developing tools for qPCR assay development and next-generation sequencing library preparation to support research and diagnostic workflows. The organization operates with a small team, and its technologies and product lines are now being developed and commercialized within the G3 Genomics portfolio, with SeqOnce-branded reagent kits handled by Bandit Bio. This transition reflects ongoing activity in the same scientific area, even as the company’s assets move under new management. A notable recent development is the July 2025 launch of an RT-qPCR Measles Panel, expanding the range of pathogen assays associated with SeqOnce. The firm has a history of releasing infectious-disease testing solutions and has previously expanded its Carlsbad facilities and released SARS-CoV-2 testing kits, indicating a continued emphasis on tools to detect and analyze human disease.